key: cord-0924535-gg1mcyyz
authors: Degeneffe, Aurélie; Bruneau, Michaël; Spitaels, Julien; Gilis, Nathalie; De Witte, Olivier; Lubansu, Alphonse
title: Acute hemorrhage after intra-cerebral biopsy in COVID-19 patients: a report of 3 cases
date: 2020-06-09
journal: World Neurosurg
DOI: 10.1016/j.wneu.2020.06.016
sha: c37647d030cbb5f753862c3797d85df716991d0f
doc_id: 924535
cord_uid: gg1mcyyz

Abstract Background When Belgium’s COVID-19 outbreak began in March of 2020, our neurosurgical department followed the protocol of most surgical departments in the world and postponed elective surgery. However, patients with tumor-like brain lesions requiring urgent surgery still received treatment as usual, in order to ensure ongoing neuro-oncological care. From a series of 31 patients admitted for brain surgery, three were confirmed as infected by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Case description We present the clinical outcomes of these three COVID-19 patients, who underwent an intra-cerebral biopsy in our department during April of 2020. All suffered from a diffuse intra-parenchymal hemorrhage post-operatively. Unfortunately, we were not able to identify a clear etiology of these post-operative complications. It could be hypothesized that an active COVID-19 infection status may be related to a higher bleeding risk. The remaining 28 neuro-oncological non-COVID patients underwent uneventful surgery during the same period. Conclusions This case series reports the previously unreported and unexpected outcomes of COVID-19 patients suffering from acute hemorrhage after intra-cerebral biopsy procedures. Although no direct relation can yet be established, we recommend the neurosurgical community be cautious in such cases.

Background: When Belgium's COVID-19 outbreak began in March of 2020, our neurosurgical 3 department followed the protocol of most surgical departments in the world and postponed 4 elective surgery. However, patients with tumor-like brain lesions requiring urgent surgery still 5 received treatment as usual, in order to ensure ongoing neuro-oncological care. From a series of 6 31 patients admitted for brain surgery, three were confirmed as infected by the novel severe 7 acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 8

Case description: We present the clinical outcomes of these three COVID-19 patients, who 9 underwent an intra-cerebral biopsy in our department during April of 2020. All suffered from a 10 diffuse intra-parenchymal hemorrhage post-operatively. Unfortunately, we were not able to 11 identify a clear etiology of these post-operative complications. It could be hypothesized that an 12 active COVID-19 infection status may be related to a higher bleeding risk. The remaining 28 13 neuro-oncological non-COVID patients underwent uneventful surgery during the same period. 14 Conclusions: This case series reports the previously unreported and unexpected outcomes of 15 COVID-19 patients suffering from acute hemorrhage after intra-cerebral biopsy procedures. 16

Although no direct relation can yet be established, we recommend the neurosurgical community 17 be cautious in such cases. 18 Acute hemorrhage after intra-cerebral biopsy in COVID-19 patients: a report 1 of three cases 2 3

When Belgium's COVID-19 outbreak began in March of 2020, our department followed the 5 protocol of most surgical departments in the world and postponed elective surgery. However, 6 patients presenting with tumor-like brain lesions requiring urgent surgery received treatment as 7 usual, in order to ensure on-going neuro-oncological care, a practice that has been advocated in 8 recent literature. 1-4 Nonetheless, we faced a high rate of unexpected complications in three 9 COVID-19 patients. All three patients who underwent an intra-cerebral biopsy experienced a 10 postoperative hemorrhage. We feel the obligation to report the rare and unexpected outcome of 11 these cases. 12

From a series of 31 patients admitted for brain surgery, three were confirmed as infected by the 15 novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe three 16 consecutive cases of COVID-19 patients who underwent an intra-cerebral biopsy in April of 17 2020, for histopathological diagnosis. The patients were operated on by three separate, 18 experienced neurosurgeons from our department.

A 72-year-old male patient with history of repetitive falls was admitted to our department. He 2 presented with gait disturbance, disequilibrium along with multiple weeks of headaches and 3 cognitive changes. Neurological examination showed bradyphrenia, and one-step commands 4

were followed with great difficulty. A brain-MRI revealed a voluminous tumorous cystic-5 necrotic lesion centered on the corpus callosum ( Figure 1A, 1B) , which was suspected to be a 6 butterfly-glioblastoma. FDG-PET/CT imaging showed hypermetabolism in the left thalamus, 7 corpus callosum and right parieto-occipital: suspicious hypermetabolism of the prostate and a 8 T12 compression fracture were identified as well. One day after admission PCR SARS-CoV2 9 appeared positive, but chest CT was normal (CO-RADS 6). 5 The patient presented neither fever 10 nor respiratory symptoms. Coagulation tests were normal (Table 1) and he was not taking any 11 anti-coagulant nor undergoing anti-platelet therapy. Following protocol, he was admitted to our 12 hospital's COVID department. Ten days after admission, biopsy of the lesion was performed. A 13 neuro-navigation-guided biopsy was performed first, but quality of the obtained tissue was 14 insufficient. Subsequently, a 15mm-diameter occipital craniotomy was conducted for an open 15 biopsy given the adequate access for tissue sampling. Several greyish tumoral samples were 16 taken and proper hemostasis was obtained at the end of the procedure. Histopathological analysis the patient presented with left-hemiparesis and an altered level of consciousness. A brain- CT 19 found an intra-parenchymal hemorrhage (IPH) of 2,5x3x3cm in the operative site with midline-20 shift ( Figure 1C ). Given the gloomy prognosis and limited hematoma size, no surgical 21 evacuation was performed, and no subsequent CT scans were carried out. The patient passed 22 away on postoperative day six with the aid of comfort care. 23

A 63-year-old male patient with history of an inaugural tonic-clonic seizure was transferred to 2 our center. The patient was on anti-platelet therapy (acetylsalicylic acid), which was stopped 3 upon admission. Neurological examination revealed dysarthria, left facial paralysis and left-4 hemiparesis. Coagulation tests were normal (Table 1 ). Brain-MRI revealed an infiltrative 5 tumorous cystic-necrotic lesion right fronto-parieto-temporo-insular, suspected to be a high-6 grade glioma (Figure 2A ). FDG PET-CT showed hypermetabolism in the cerebral lesion, 7

confirming the suspicion of high-grade glioma; bilateral hypermetabolic pulmonary 8 consolidations were identified as well. Although PCR SARS-CoV2 was negative three times, 9

Thorax-CT was highly suspicious for COVID-19 including the typical COVID-19 CT findings 10 according to the CO-RADS classification. 5 The patient presented only once an episode of fever 11 and no respiratory symptoms. He was then transferred to the COVID ward. Twelve days after 12 admission a stereotactic needle biopsy of the lesion was performed through a right frontal burr-13 hole ( Figure 2B ). Histopathological analysis confirmed diagnosis of an anaplastic astrocytoma, 14 WHO grade 3. Postoperatively, alteration of consciousness was observed in the form of Glasgow 15 coma scale 8/15. CT imaging showed a large multifocal IPH of 4,5x6x6,8cm in the right frontal 16 lobe with major perilesional oedema and midline-shift ( Figure 2C ). Subsequently, intracranial 17 pressure, brain tissue oxygen and intra-cerebral electroencephalography monitoring were 18 inserted right frontally. In the following hours, the IPH continued to enlarge discretely ( Figure  19 2D) and the patient developed an intra-ventricular hemorrhage (IVH) associated with a 20 ventricular dilatation; a left extra-ventricular drain was then inserted. After discussion with the 21 patient's family, about the gloomy prognosis, it was decided that a surgical evacuation of the

A 78-year-old male with a month-long history of headaches was admitted with confusion, 2 reduced verbal fluency and left hemi-hypoesthesia. Two months earlier, the patient was 3 diagnosed with a prostatic adenocarcinoma with right iliac lymph node invasion. Brain-MRI 4 revealed a cortical and meningeal contrast enhancement in the right parietal region ( Figure 3A) . 5

This could be compatible with leptomeningeal metastasis (LM). FDG PET-CT showed 6 hypometabolic activity in the left parieto-temporal region, a hypermetabolic thyroid lesion and a 7 hypermetabolic lymph node in the right iliac. These findings were not in favor of LM. Two 8 lumbar punctures did not reveal malignant cells. Two PCR SARS-CoV2 were positive, as was 9

thorax-CT (CO-RADS 6). 5 The patient presented neither fever nor respiratory symptoms. 10

Fourteen days after admission, meningeal biopsy was performed through a right parietal burr-11

hole. His anti-platelet therapy (acetylsalicylic acid) was terminated 7 days prior to biopsy. We 12 observed mild thrombocytopenia, increased D-dimer concentrations and slightly prolonged 13 prothrombin time (PT) ( Table 1) COVID-19 has been associated with coagulopathies such as disseminated intravascular 20 coagulation (DIC) leading to thrombosis. [9] [10] [11] Subsequently, consumption of platelets in DIC can 21 result in hemorrhage. 12 Panciani et al. described four COVID patients undergoing surgery or 22 embolization for chronic subdural hematoma with a mortality rate of 100%. In two cases, a thrombocytopenia was observed, and led to re-bleeding postoperatively. 13 Thrombocytopenia, 1 elevated D-dimer and prolonged PT has been associated with 14 In our series, we 2 observed alteration of these coagulation parameters in one case. Acetylsalicylic acid was 3 discontinued seven days prior to surgery as is recommended. 4

The overall hemorrhage complication rate in non-immunocompromised patients after stereotactic 6 biopsy ranges from 1-3%. All three COVID-19 patients who underwent surgery during one-7 month-period suffered from a hemorrhagic complication. Also throughout this month, 28 non-8 COVID-patients underwent uneventful operations for brain tumors. 9

We emphasize that in these described cases only a small amount of brain tissue was sampled, a 10 fact which resulted in an unusually large diffuse hematoma. Two cases became symptomatic 11 after 24 hours, which is unusual. We were not able to identify a clear etiology for these 12 presentations. cells. This may be leading to the disruption of auto-regulation as well as to blood pressure spikes 16 due to arterial wall rupture. 7 ACE-II is widely expressed throughout the human brain, mostly in 17 glial cells. 15, 16 Two of our patients underwent biopsy of a high-grade glioma; it could be 18 suggested that bleeding risk is higher due to dysregulation in these ACE-II-receptors within the 19 glial cells, although our immunohistochemistry analyses for anti-SARS-CoV were all negative 20 on the obtained cerebral tissues. 21

In addition, the surgical procedures themselves present a complication: they are more difficult to 1 perform while wearing the mandatory personal protective equipment. 3 The face shield especially 2 may impair vision and does not facilitate the use of a microscope. However the authors do not 3 consider technical difficulties to be responsible for these hemorrhagic complications. 4

No causal relationship can be confirmed for tumor-biopsy-surgery in COVID-19-patients based 6 on three cases alone. Nonetheless, we urge the neurosurgical community to take our findings into 7 consideration before pursuing such procedures in this particular population. 8 9

With this case-series we want to alert the neurosurgical community to the unexpected high risk 11 of postoperative hematoma after tumor biopsy in COVID-19 patients. 12

The Institutional Board Review (Brussels, Belgium) approved the study and accepted exemption 2 of informed consent giving the circumstances. 3 4 Acknowledgements 5

The authors would like to express our gratitude to Dr. Claire Royer-Chardon who provided 6 additional information regarding the interpretation of the immunohistochemistry analyses for 7 anti-SARS-CoV. 8 9

The research did not receive any specific grant from funding agencies in the public, commercial, 11

or not-for-profit sectors. 

Letter : Surgical Management of Brain Tumor 12 Patients in the COVID-19 Era

CO-RADS -A categorical CT 14 assessment scheme for patients with suspected COVID-19: definition and evaluation

Epidemiological and clinical characteristics of 99 cases 2 of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Abnormal coagulation parameters are associated with poor 5 prognosis in patients with novel coronavirus pneumonia

Coagulation abnormalities and 8 thrombosis in patients with COVID-19

Disseminated Intravascular Coagulation: An 11

Update on Pathogenesis, Diagnosis, and Therapeutic Strategies

Letter : 14 COVID-19 Infection Affects Surgical Outcome of Chronic Subdural Hematoma

Clinical Characteristics of Coronavirus Disease

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: